Valuation : Circio Holding ASA

Market Cap 3.5B 378M 325M 308M 279M 520M 36.07B 526M 3.65B 1.41B 18.32B 1.42B 1.39B 57.64B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 3.51B 378M 326M 308M 279M 520M 36.09B 526M 3.65B 1.41B 18.34B 1.42B 1.39B 57.68B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -
1 day-1.39%
1 week+4.59%
Current month-1.24%
1 month+45.00%
3 months+58.90%
6 months+286.67%
Current year+996.22%
1 week 12.5
Extreme 12.5
13.8
1 month 8.34
Extreme 8.34
15.7
Current year 0.98
Extreme 0.978
15.7
1 year 0.58
Extreme 0.584999
15.7
3 years 0.48
Extreme 0.48
15.7
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 2021-10-19
Director of Finance/CFO 58 2022-03-06
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 79 2015-06-30
Director/Board Member 66 2015-09-13
Chairman 64 2020-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
11/30/21 Exercice

Chief Executive Officer

120,000 0.1386%
5/19/21 Buy

Director

21,299 0.0246%
12/3/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%+4.59%+1,912.62%+3.87% 383M
-2.11%-3.44%+41.04%+98.48% 68.24B
-0.23%-6.42%+30.19%+76.15% 62.23B
+1.67%+2.16%-11.32%+392.80% 27.8B
-1.05%-7.30%+25.00%+12.31% 24.86B
+0.34%-5.98%-4.23%-19.48% 24.22B
+0.43%-4.78%+18.26%-20.61% 19.36B
-3.03%-5.19%+192.88%+340.13% 17.28B
-1.94%-6.36%-7.05%+516.16% 14.46B
-2.28%-5.09%+48.86%+153.82% 14.23B
Average -0.96%-2.96%+224.63%+155.36% 27.31B
Weighted average by Cap. -0.86%-3.79%+36.24%+136.77%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.2M 5.34M 5.06M 4.58M 8.53M 592M 8.64M 59.92M 23.08M 301M 23.27M 22.76M 946M -45.91M -4.95M -4.26M -4.04M -3.65M -6.81M -473M -6.89M -47.82M -18.42M -240M -18.57M -18.16M -755M
Net Debt -972K -105K -90.24K -85.44K -77.36K -144K -10M -146K -1.01M -390K -5.08M -393K -385K -15.99M 2.24M 242K 208K 197K 179K 333K 23.11M 337K 2.34M 901K 11.74M 908K 888K 36.93M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
11
Date Price Change Volume
26-09-11 NOK 12.76 -1.39% 3,271,926
26-09-10 NOK 12.94 -0.31% 6,260,067
26-09-09 NOK 12.98 -2.55% 2,983,578
26-09-08 NOK 13.32 +0.60% 10,294,871
26-09-07 NOK 13.24 +2.32% 8,551,271

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!